Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zogenix announces patent for DosePro Needle-free Delivery System
Yahoo/Fly on the Wall
Monday, July 14, 2014 - 9:29am
tags:
Zogenix, DosePro, drug delivery, patents
U.K. ready to toughen up takeover rules; Stricter laws would follow Pfizer’s failed bid for AstraZeneca
Marketwatch
Monday, July 14, 2014 - 9:22am
tags:
M&A, UK, Pfizer, AstraZeneca
If AbbVie Succeeds There Could Be a Homecoming for Shire
WSJ Online
Monday, July 14, 2014 - 9:16am
tags:
AbbVie, Shire, M&A
German database study hints diabetes drug cuts Alzheimer's risk
Yahoo/Reuters
Monday, July 14, 2014 - 9:15am
tags:
Germany, diabetes, Alzheimer's disease, Actos, Takeda
AbbVie Moves Closer to Shire Deal With $53.7 Billion Bid
Bloomberg
Monday, July 14, 2014 - 9:11am
tags:
Shire, AbbVie, M&A
Big pharma weigh sell-off of old drugs
The Telegraph, UK
Sunday, July 13, 2014 - 11:46am
tags:
New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice
Yahoo/PR NewsWire
Sunday, July 13, 2014 - 11:16am
tags:
Alzheimer's disease, Eli Lilly
U.K. to Tighten Rules for Foreign Bidders, Cable Says
Bloomberg
Sunday, July 13, 2014 - 11:12am
tags:
UK, M&A
Where Are We At With AbbVie's Acquisition Of Shire? (ABBV)
Seeking Alpha
Sunday, July 13, 2014 - 11:10am
tags:
AbbVie, Shire, M&A
Mylan near multibillion-dollar deal for Abbott drug assets - sources
Global Post
Saturday, July 12, 2014 - 12:04pm
tags:
Mylan, Abbott Laboratories
The FDA is Cracking Down on Big Pharma Social Media
Time
Saturday, July 12, 2014 - 11:35am
tags:
social media
Roche Collaborates with Merck KGaA
Yahoo/Zacks
Saturday, July 12, 2014 - 11:08am
tags:
Roche, Merck KGaA, diagnostics
Is This MannKind's Greatest Risk?
Motley Fool
Saturday, July 12, 2014 - 10:39am
tags:
MannKind, Afrezza
1 Drug More Important to Gilead Than Sovaldi
Motley Fool
Saturday, July 12, 2014 - 10:37am
tags:
Truvada, Gilead Sciences, HIV
Johnson & Johnson Earnings Preview: Pharma Buisness To Remain Strong
Seeking Alpha
Saturday, July 12, 2014 - 10:35am
tags:
JNJ, earnings
A Global Pharma Boom Is Coming... Here's How To Profit
Yahoo/Street Authority
Saturday, July 12, 2014 - 10:34am
tags:
Sanofi
England Asks Illumina to Map 100,000 Genomes
Bloomberg
Saturday, July 12, 2014 - 10:32am
tags:
Illumina, genome sequencing
France Not Retreating from Gilead Sciences (video)
Motley Fool
Saturday, July 12, 2014 - 10:29am
tags:
France, Gilead Sciences, Sovaldi, hepatitis C
Oncolytics Up on Patient Enrolment Completion
Yahoo/Zacks
Saturday, July 12, 2014 - 10:27am
tags:
Oncolytics
U.S. senators ask Gilead to explain cost of Sovaldi hepatitis drug
Yahoo/Reuters
Saturday, July 12, 2014 - 10:26am
tags:
Gilead Sciences, Sovaldi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.